Turing Pharmaceuticals: Fair Profit or Price Gouging in the Drug Industry? Case Solution
Abstract:
Turing's choice to raise the price of its anti-infection drug Daraprim, from $13.50 to $750 per dosage, is emblematic of the argument about the duties of pharmaceutical business and service more typically. The case asks: Do prescription executives have a duty to clients when setting drug rates, or are they beholden just to their investors? While set mostly in the United States, the case raises concerns of business social obligation and public policy for the international health care market and service more usually.
This is just an excerpt. This case is about Responsibility
Related Case Solutions & Analyses:
ServerVault: Reliable Secure and Wicked Fast (V. 1.5)
Hilton HHonors Worldwide: Loyalty Wars
Bajaj Auto Ltd.
Note on Taxation
Allied Chemical Corp. (B)
Note on Market and Consumer Research
McGregors Ltd. Department Store
Managing Interpersonal Conflict
Cumberland Metal Industries (C): Model Year 1979 Negotiations with Beta Motors
Allen Distribution Co.
